1st Quarter - Report

GREATER NEW YORK HOSPITAL ASSOCIATION for GREATER NEW YORK HOSPITAL ASSOCIATION

Firm
Client
Income
—
Expenses
$640,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Support for repealing the provisions related to SALT enacted in the Tax Cuts and Jobs Act.

LobbyistCovered position, as disclosed
JONATHAN COOPER —
KENNETH E RASKE —
DAVID C RICH —
SETH DEAN WARSHAW —

Contacted: HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Federal Emergency Management Agency (FEMA); White House Office; Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC)

Medicare/Medicaid MMM

Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act. Support a delay of the Medicaid DSH cuts. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79) with CMS staff. Oppose cuts to the 340B program. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care.

LobbyistCovered position, as disclosed
JONATHAN COOPER —
KAREN SMOLER HELLER —
TIM JOHNSON —
LEE H PERLMAN —
KENNETH E RASKE —
DAVID C RICH —
SETH DEAN WARSHAW —
ELISABETH R WYNN —

Contacted: SENATE; Federal Emergency Management Agency (FEMA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Management & Budget (OMB); White House Office; Substance Abuse & Mental Health Services Administration (SAMHSA); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA)

Bills named: S. 384 (116th), H.R. 1763 (116th)

Pharmacy PHA

Discuss issues related to group purchasing organizations (GPOs) with Congressional staff and members. Discuss several pieces of legislation with Congressional staff including: the CREATES Act (H.R. 965/S. 340) (support), the Fast Access for Safe & Timely Generics Act (H.R. 985) (support), the Protecting Consumer Access to Generic Drugs Act (H.R. 1499) (support), the Fair and Immediate Release of Generic Drugs Act (H.R. 1506) (support), the Orange Book Transparency Act (H.R. 1503) (support), the Purple Book Continuity Act (H.R. 1520) (support), and the Bringing Low-Cost Options and Competition While Keeping Incentives for New Generics Act (H.R. 938) (support).

LobbyistCovered position, as disclosed
JONATHAN COOPER —
LEE H PERLMAN —
KENNETH E RASKE —
DAVID C RICH —
AISLING WARDE ZACCARELLI —
SETH DEAN WARSHAW —

Contacted: Medicare Payment Advisory Commission (MedPAC); SENATE; Office of Management & Budget (OMB); Substance Abuse & Mental Health Services Administration (SAMHSA); Federal Emergency Management Agency (FEMA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); White House Office; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 340 (116th), H.R. 965 (116th), H.R. 1520 (116th), H.R. 1506 (116th), H.R. 985 (116th), H.R. 1499 (116th), H.R. 938 (116th), H.R. 1503 (116th)

Budget/Appropriations BUD

Oppose the hospital provisions in the White House's FY 2020 budget blueprint. Oppose the inclusion of language that would limit HHS and its relevant subcontractors' ability to implement liver allocation reforms. Support the inclusion of funding for hospital infrastructure and workforce programs in appropriations legislation. Support for the inclusion of provisions to delay the Medicaid DSH cuts in appropriations legislation.

LobbyistCovered position, as disclosed
JONATHAN COOPER —
KENNETH E RASKE —
DAVID C RICH —
SETH DEAN WARSHAW —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); White House Office; Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; Office of Management & Budget (OMB); Federal Emergency Management Agency (FEMA); Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Discuss quality and patient safety issues with CMS staff. Discuss Medicare SNF payments with MedPAC staff. Discuss Medicare DSH funding with CMS staff. Discuss Medicare GME rural training tracks in 42 CFR (413.79) with CMS staff. Discuss NYSDOH CHSLI construction waiver with HHS staff. Discuss a previously awarded grant for disaster relief resiliency with FEMA and Congressional staff. Discuss GNYHA's legislative priorities with Congressional staff: Medicaid DSH funding (support), site-neutral policies (oppose), 340B drug discount program (support), expanding federal graduate medical education programs (support), funding to address the opioid crisis (support), funding for hospital infrastructure (support), the Affordable Care Act (support), and liver allocation reforms (support). Discuss potential surprise billing legislation with Congressional staff and members. Support a delay of the Medicaid DSH cuts. Discuss the need to reform the United States' liver allocation system with Congressional staff/members, HHS, HRSA, UNOS and OPTN. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid. Oppose several provisions in the White House's FY 2020 budget blueprint, including provisions related to GME, site-neutral policies, Medicaid DSH, Medicare UCP funding, Medicare bad debt payments, provisions in the Affordable Care Act, Medicaid eligibility rules, the 340B drug discount program, and Medicare post-acute care. Discuss issues related to maternal mortality and the MOMS Act (S. 116) with Congressional staff. Discuss issues related to drug-resistant infections with Congressional staff. Discuss issues related to the Affordable Care Act (Pub.L 111-148), individual marketplace stabilization, and the expansion of Medicare and Medicaid with Congressional staff. Support graduate medical education funding through the Medicare program, including support for the Resident Physician Shortage Reduction Act (S. 384/H.R. 1763) and the Opioid Workforce Act.

Contacted: Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Substance Abuse & Mental Health Services Administration (SAMHSA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Federal Emergency Management Agency (FEMA)

Bills named: S. 116 (116th), S. 384 (116th), H.R. 1763 (116th)

Affiliated organisations

OrganisationLocation
ACURITY, INC. New York, NY, US
GNYHA MANAGEMENT CORPORATION New York, NY, US
GNYHA VENTURES, INC. New York, NY, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.